Novo Signs Up Another Oral Insulin Partner, Hedging Its Bets

 
• By The Pink Sheet Daily

Novo Nordisk places another oral insulin technology bet with Emisphere; expands partnership with Merrion beyond insulin.

More from Archive

More from Pink Sheet